Библиотека источников

Полный список источников

Все медицинские утверждения на этом сайте основаны на приведённых ниже источниках. Вы можете отфильтровать их по категории или выполнить поиск по ключевому слову.

Каждый источник снабжён ссылкой DOI для прямого доступа к оригинальной статье.

参考文献库

共 22 条文献

Hudelist et al.(2026)

CPA-associated meningioma in transgender women

eClinicalMedicine

DOI: 10.1016/j.eclinm.2026.103791

Poage AC et al.(2026)

Subcutaneous vs Intramuscular Estradiol Valerate Injection

Pharmacy

DOI: 10.3390/pharmacy14010013

Kanin M et al.(2025)

Injectable Estradiol Dosing Regimens

Journal of the Endocrine Society

DOI: 10.1210/jendso/bvaf004

Misakian AL et al.(2025)

Injectable Estradiol Monotherapy in Transgender Individuals

Endocrine Practice

DOI: 10.1016/j.eprac.2025.07.002

Rothman MS et al.(2024)

Injectable Estradiol Dosing in Transgender Individuals

Transgender Health

DOI: 10.1089/trgh.2023.0209

Herndon JS et al.(2023)

Subcutaneous vs Intramuscular Estradiol Valerate

Endocrine Practice

DOI: 10.1016/j.eprac.2023.02.006

富士製薬(2023)

プロギノン・デポー添付文書

PMDA

Link

Coleman E et al.(2022)

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8

International Journal of Transgender Health

DOI: 10.1080/26895269.2022.2100644

Lee et al.(2022)

Cyproterone acetate and meningioma risk

Scientific Reports

DOI: 10.1038/s41598-022-05773-z

de Blok CJM et al.(2021)

Amsterdam cohort 50-year follow-up

The Lancet Diabetes & Endocrinology

DOI: 10.1016/S2213-8587(21)00185-6

Patel et al.(2021)

Breast development in transgender women on hormone therapy

Transgender Health

DOI: 10.1089/trgh.2020.0057

Aly(2021)

Injectable Estradiol Meta-Analysis

Transfeminine Science

Link

Meyer et al.(2020)

Safety and rapid efficacy of guideline-based gender-affirming hormone therapy

European Journal of Endocrinology

DOI: 10.1530/EJE-19-0463

EMA(2020)

Restrictions on use of cyproterone due to meningioma risk

European Medicines Agency

Link

Vinogradova Y et al.(2019)

Use of hormone replacement therapy and risk of venous thromboembolism

BMJ

DOI: 10.1136/bmj.k4810

Prior JC(2019)

Progesterone is important for transgender women's therapy

The Journal of Clinical Endocrinology & Metabolism

DOI: 10.1210/jc.2018-01777

Canonico M et al.(2018)

Hormone therapy and venous thromboembolism: an updated overview

Maturitas

DOI: 10.1016/j.maturitas.2015.06.040

Hembree WC et al.(2017)

Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons

The Journal of Clinical Endocrinology & Metabolism

DOI: 10.1210/jc.2017-01658

Deutsch(2016)

Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People

UCSF Gender Affirming Health Program

Link

Kuhl(2005)

Pharmacology of estrogens and progestogens: influence of different routes of administration

Climacteric

DOI: 10.1080/13697130500148875

Price et al.(1997)

Sublingual estradiol pharmacokinetics

Obstetrics & Gynecology

DOI: 10.1016/S0029-7844(96)00513-3

Oriowo MA et al.(1980)

Pharmacokinetics of Estradiol Esters

Contraception

DOI: 10.1016/S0010-7824(80)80018-7